What are the diagnostic criteria for Brugada syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Brugada Syndrome

Brugada syndrome is diagnosed by the presence of a coved (type 1) ST-segment elevation ≥2 mm in leads V1 or V2 positioned in the second, third, or fourth intercostal space, occurring either spontaneously or after sodium channel blocker challenge, in the absence of other causes of ST elevation. 1

Core Electrocardiographic Criteria

The diagnosis hinges on identifying the type 1 Brugada ECG pattern, which consists of:

  • Coved ST-segment elevation ≥2 mm in right precordial leads V1 and/or V2
  • Negative T waves in the right precordial leads
  • Must be recorded with leads positioned in the 2nd, 3rd, or 4th intercostal space (higher positioning improves detection) 1
  • Must exclude other causes of ST elevation 1

Important distinction: Only the type 1 (coved) pattern is diagnostic. The type 2 and 3 patterns (saddle-back configurations) are not diagnostic by themselves and require provocation testing or additional clinical criteria 2.

When the Pattern Appears

The type 1 ECG pattern may manifest:

  • Spontaneously (highest risk patients)
  • During fever (common trigger in children and adults)
  • During vagotonic states
  • After sodium channel blocker challenge (ajmaline, flecainide, procainamide, pilsicainide) 1

Sodium Channel Blocker Challenge Testing

Indications for drug challenge:

  • Patients with suspected Brugada syndrome who lack spontaneous type 1 pattern at baseline
  • Should be terminated if ventricular arrhythmias, marked QRS widening, or type 1 pattern develops 1

Not indicated:

  • Asymptomatic patients who already have type 1 pattern (no additional diagnostic value) 1
  • Generally avoided in children until after puberty, with limited exceptions 3

Clinical Context and Risk Stratification

While the ECG pattern is the diagnostic cornerstone, clinical features help identify highest-risk patients:

  • History of cardiac arrest or documented VF (highest risk)
  • Syncope (particularly arrhythmogenic syncope)
  • Family history of sudden cardiac death <45 years
  • Documented ventricular tachycardia
  • Inducibility of VT at electrophysiological study 1

Critical point: Patients with spontaneous type 1 pattern plus syncope or prior cardiac arrest are at highest risk for lethal ventricular arrhythmias and have demonstrated mortality benefit from ICD implantation 1.

Important Caveats and Pitfalls

Rule out Brugada phenocopies - conditions that mimic the ECG pattern but are not true Brugada syndrome:

  • Right bundle branch block
  • Acute coronary syndromes (especially LAD or RCA conus branch occlusion)
  • Arrhythmogenic right ventricular cardiomyopathy
  • Pectus excavatum
  • Electrolyte abnormalities (hypokalemia/hyperkalemia)
  • Cocaine poisoning
  • Athletes 2, 4

The ECG pattern can be dynamic - it may appear and disappear, sometimes only captured during fever or with high lead placement. Repeated ECGs and 24-hour Holter monitoring may be necessary 5.

Role of Genetic Testing

  • Genetic testing yields positive results in only 20-30% of phenotype-positive patients 1
  • SCN5A is the most common gene involved 1, 3
  • A negative genetic test does NOT exclude Brugada syndrome - diagnosis remains primarily electrocardiographic and clinical 1
  • Genetic testing is most useful for cascade screening of family members once a pathogenic variant is identified 1
  • Genotype status does not correlate with risk of adverse events 1

Practical Diagnostic Algorithm

  1. Identify type 1 ECG pattern (coved ST elevation ≥2 mm in V1/V2 in 2nd-4th intercostal space)
  2. Exclude phenocopies and other causes of ST elevation
  3. If no spontaneous type 1 pattern but clinical suspicion exists, consider sodium channel blocker challenge
  4. Assess clinical risk factors (syncope, cardiac arrest, family history)
  5. Consider genetic testing for family screening purposes, not for diagnosis or risk stratification

The diagnosis is fundamentally electrocardiographic, with the type 1 pattern being both necessary and sufficient when other causes are excluded 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.